IMGN NASDAQ
ImmunoGen, Inc.
1W: +5.8%
1M: +4.9%
3M: +111.6%
1Y: +617.9%
3Y: +292.8%
5Y: +439.4%
$31.23
Last traded 2024-02-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$288M
Revenue
+200.8% YoY
$-73M
Net Income
+64.1% YoY
$-200M
Free Cash Flow
+7.9% YoY
98.1%
Gross Margin
22.9%
Op. Margin
27.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-19.8%
ROA-12.4%
ROIC-224.8%
Valuation
P/E-35.5
P/B50.8
EV/EBITDA-64.2
Leverage
Debt/Equity0.13
Current Ratio5.47
Interest Cov.-17.3x
Quality Scores
Piotroski F4/9
Altman Z8.55
Beneish M7.73